BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.
Metrics to compare | 377740 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship377740PeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | 14.0x | −0.5x | |
PEG Ratio | 0.02 | 0.04 | 0.00 | |
Price / Book | 0.4x | 1.5x | 2.6x | |
Price / LTM Sales | 4.5x | 2.8x | 3.2x | |
Upside (Analyst Target) | - | 26.6% | 44.2% | |
Fair Value Upside | Unlock | 13.5% | 5.5% | Unlock |